Heron Therapeutics (HRTX) Construction in Progress (2011 - 2025)

Heron Therapeutics has reported Construction in Progress for 13 years, with the latest figure at $1.7 million in Q4 2025.

• For the quarter ending Q4 2025, Construction in Progress fell 34.62% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (down 34.62% YoY), and the FY2025 full-year result was $1.7 million, down 34.62% from the prior year.
• Construction in Progress for Q4 2025 stood at $1.7 million, down from $2.6 million in the prior quarter.
• The five-year high for Construction in Progress was $15.9 million in Q4 2021, with the low at $1.7 million in Q4 2025.
• Historically, Construction in Progress has averaged $6.4 million across 5 years, with a median of $5.4 million in 2022.
• Annual changes were most pronounced in 2022 — Construction in Progress slumped 66.04% — and 2023, when it gained 16.67%.
• Heron Therapeutics' Construction in Progress stood at $15.9 million in 2021, then slumped by 66.04% to $5.4 million in 2022, then rose by 16.67% to $6.3 million in 2023, then slumped by 58.73% to $2.6 million in 2024, then tumbled by 34.62% to $1.7 million in 2025.
• The last three Construction in Progress figures came in at $1.7 million (Q4 2025), $2.6 million (Q4 2024), and $6.3 million (Q4 2023), per Business Quant data.